|   | 
                                                        Potential SARS-CoV-2 Spike Protein-ACE2 Interface Inhibitors: Repurposing FDA-approved Drugs
                                                    
                                                        Valentina L. Kouznetsova, Aidan Zhang, Mark A. Miller, Mahidhar Tatineni, Jerry P. Greenberg, Igor F. Tsigelny
                                                     
                                                        Published online: December 24, 2021
                                                     
                                                        J Explor Res Pharmacol. 2021;7(1):17-29.  doi:10.14218/JERP.2021.00050
                                                     |